Form 4: Pfizer CEO Bourla Acquires 83 Phantom Stock Units

Pfizer Chairman and CEO Albert Bourla acquired 83 phantom stock units under a deferred compensation plan, increasing his beneficial ownership to 731,058 units.

Summary

• Albert Bourla, Chairman & CEO of Pfizer Inc., acquired 83 phantom stock units.
• The transaction occurred on October 14, 2025.
• Each unit represents one phantom share of common stock, priced at $24.52.
• These units were acquired through the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan.
• Following this acquisition, Bourla beneficially owns 731,058 phantom stock units.
• The units are settled in cash upon separation from service and can be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 6

Explanation: Routine insider acquisition of phantom stock units under a deferred compensation plan, indicating continued executive alignment with company performance without significant new information.

Positives

• Chairman & CEO Albert Bourla increased his beneficial ownership of phantom stock units, aligning his interests with shareholders.
• The acquisition was part of a deferred compensation plan, indicating a structured approach to executive compensation.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Increased alignment of the CEO's interests with shareholder value through phantom stock ownership.
• Employees: Reflects standard executive compensation practices within the company.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of phantom stock units by the CEO as part of a deferred compensation plan. Such transactions are common and generally do not signal a significant change in the company's fundamental outlook or warrant a change in investment recommendation. It primarily indicates continued executive alignment.

Keywords

Pfizer, PFE, Albert Bourla, insider transaction, Form 4, phantom stock, deferred compensation, CEO, director